Dave Osterman

Dave Osterman is an experienced research professional with expertise in therapeutic research activities from target identification through early development. He is skilled at evaluation of therapeutic assets and leading high performing teams in Complement Exploratory Biology and in vitro and in vivo Pharmacology. Dave is retired from Alexion Pharmaceuticals, last serving as executive director.